Items where authors include "Flaxman, A"

Article

Tomic, A, Skelly, DT, Ogbe, A et al. (105 more authors) (2022) Divergent trajectories of antiviral memory after SARS-CoV-2 infection. Nature Communications, 13 (1). 1251. ISSN 2041-1723

Dejnirattisai, W, Huo, J, Zhou, D et al. (461 more authors) (2022) SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell, 185 (3). 467-484.e15. ISSN 0092-8674

Flaxman, A, Marchevsky, NG, Jenkin, D et al. (184 more authors) (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). The Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736

Ogbe, A, Kronsteiner, B, Skelly, DT et al. (77 more authors) (2021) T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nature Communications, 12 (1). 2055.

Voysey, M, Costa Clemens, SA, Madhi, SA et al. (763 more authors) (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736